These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 7533260

  • 1. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T, van Agthoven TL, Dekker A, Foekens JA, Dorssers LC.
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [Abstract] [Full Text] [Related]

  • 2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE, Madsen MW, Briand P.
    Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264
    [Abstract] [Full Text] [Related]

  • 3. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D, Philips A, Galtier F, Rochefort H.
    Endocrinology; 1993 Aug 15; 133(2):571-6. PubMed ID: 8344199
    [Abstract] [Full Text] [Related]

  • 4. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells.
    van Agthoven T, van Agthoven TL, Portengen H, Foekens JA, Dorssers LC.
    Cancer Res; 1992 Sep 15; 52(18):5082-8. PubMed ID: 1516065
    [Abstract] [Full Text] [Related]

  • 5. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E, Duchesne MJ, Semlali A, Fuentes M, Giamarchi C, Richard-Foy H, Nicolas JC, Pons M.
    Cancer Res; 2000 Aug 01; 60(15):4130-8. PubMed ID: 10945620
    [Abstract] [Full Text] [Related]

  • 6. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol.
    Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC.
    Mol Cell Endocrinol; 1992 Dec 01; 90(1):77-86. PubMed ID: 1301400
    [Abstract] [Full Text] [Related]

  • 7. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brünner N, Wang Y, Clarke R.
    Cancer Res; 2002 Jun 15; 62(12):3428-37. PubMed ID: 12067985
    [Abstract] [Full Text] [Related]

  • 8. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P, Garcia M, Brünner N, Derocq D, Clarke R, Rochefort H.
    Int J Cancer; 1994 Jan 15; 56(2):295-300. PubMed ID: 8314314
    [Abstract] [Full Text] [Related]

  • 9. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
    Coradini D, Biffi A, Pirronello E, Di Fronzo G.
    Anticancer Res; 1995 Jan 15; 15(6B):2557-61. PubMed ID: 8669823
    [Abstract] [Full Text] [Related]

  • 10. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 15; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS, Pink JJ, Jordan VC.
    Cancer Res; 1990 Nov 15; 50(22):7285-92. PubMed ID: 2224859
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y, Ballejo G, Murphy LC, Murphy LJ.
    Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100
    [Abstract] [Full Text] [Related]

  • 13. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP.
    Anticancer Res; 2003 Apr 01; 23(2B):1455-60. PubMed ID: 12820409
    [Abstract] [Full Text] [Related]

  • 14. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW, Martin J, Lynch M.
    Br J Cancer; 1990 Apr 01; 61(4):504-7. PubMed ID: 2139575
    [Abstract] [Full Text] [Related]

  • 15. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM.
    Cancer Res; 1996 Dec 01; 56(23):5403-9. PubMed ID: 8968093
    [Abstract] [Full Text] [Related]

  • 16. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.
    Daly RJ, Darbre PD.
    Cancer Res; 1990 Sep 15; 50(18):5868-75. PubMed ID: 2393857
    [Abstract] [Full Text] [Related]

  • 17. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G, Katzenellenbogen BS.
    Mol Cell Endocrinol; 1999 Mar 25; 149(1-2):93-105. PubMed ID: 10375022
    [Abstract] [Full Text] [Related]

  • 18. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM, LaSpina M, Long J, Ho SM.
    Cancer Res; 2000 Jun 15; 60(12):3175-82. PubMed ID: 10866308
    [Abstract] [Full Text] [Related]

  • 19. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 20. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ.
    Oncogene; 1995 Jun 15; 10(12):2435-46. PubMed ID: 7784095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.